华润医药完成发行 11 亿元公司债券
According to the Zhitong Finance APP, CHINARES PHARMA announced that the first phase of its 2025 corporate bonds, with a total principal amount of RMB 1.1 billion, has been issued. The term is three years, with a coupon annual interest rate of 1.82%. The net proceeds will be used for productive expenditures, including repaying corporate debts, supplementing working capital, project development and operational expenditures, investments related to technological innovation, and other uses that comply with applicable laws and regulations
According to the Zhitong Finance APP, CHINARES PHARMA (03320) announced that the first phase of its corporate bonds for 2025, with a total principal amount of RMB 1.1 billion, has been issued. The bonds have a term of three years and a coupon annual interest rate of 1.82%. The net proceeds will be used for productive expenditures, including repaying corporate debts, replenishing working capital, project development and operational expenditures, investments related to technological innovation, and other uses that comply with applicable laws and regulations
